TA Associates has announced a strategic growth investment in Healix.

Healix, based in Sugar Land, Texas, is a provider of infusion therapy management services and compounded intravenous pharmaceuticals for physician practices and hospitals.

TA Associates, a global PE firm based in Boston, invests in healthcare and several other sectors. With North American companies, TA seeks to make investments ranging from $50 million to $500 million in growing, profitable companies.

Financial terms of the transaction were not disclosed.